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Abstract
Background: The details of interaction in a complex between potent antagonists such as long
chain  α-neurotoxins and α-conotoxins with nicotinic acetylcholine receptor (nAChR), and
conformational changes induced by these antagonists, are not yet clear.
Modeling: In order to uncover some of these critical structural features, we conducted a docking
simulation and a molecular dynamics simulation (MD) of a model of the ligand binding domain of
nAChR in complex with a long-chain α-neurotoxin and an α-conotoxin.
Results: Our docking results confirm the claim that T.nAChR is in the basal or resting state, which
favors binding to the alpha-neurotoxins. Moreover, more correct "hits" for the α/γ interface upon
docking for conotoxin-nAChR confirm the preference of conotoxin GI for the α/γ interface. More
importantly, upon binding of α-neurotoxin, ligand-bonded nAChR is less dynamic in certain
domains than the apo form of the conotoxin-AChR complex. Some critical interactions in the
binding site such as the salt bridge formed between K145/D200 in the neurotoxin-nAChR complex
is further stabilized during the MD simulation, while it is obviously more labile in the apo form.
Conclusion: These observations could support the claim that alpha neurotoxins stabilize the
nAChR resting state.
Background
The nicotinic acetylcholine receptor (nAChR) is a member
of the Cys-loop superfamily of ligand-gated ion channels
(LGIC), which includes the neuronal acetylcholine recep-
tor, the γ-aminobutyric acid receptor (GABAAR), the sero-
tonin type 3 receptors (5-HT3R) and glycine receptors
(GlyR) [1,2]. In general, AChRs can be divided into two
main families: muscle type and neuronal nAChRs [3]. The
muscle type is a heteropentamer consisting of α1, β1, δ and
γ or ε subunits in the stochiometries (α1)2β1γδ or
(α1)2β1εδ in embryonic or adult receptors, respectively.
The extracelluar amino-terminal domain of nAChRs is
approximately 210 amino acid residues long and contains
binding sites for agonists and competitive antagonists
located at the α-γ and α-δ subunit interfaces [4,5]. These
two binding sites are non-equivalent and competitive
antagonists show different affinities for them [5]. When a
ligand binds, a chain reaction of conformational changes
begins in the ligand binding domain (LBD) that is trans-
mitted to the transmembrane domain (TMD), resulting in
either an open form that allows the passage of ions across
the channel, or a closed form that does not.
Published: 11 February 2009
Theoretical Biology and Medical Modelling 2009, 6:3 doi:10.1186/1742-4682-6-3
Received: 5 June 2008
Accepted: 11 February 2009
This article is available from: http://www.tbiomed.com/content/6/1/3
© 2009 Nasiripourdori et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Theoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
Page 2 of 15
(page number not for citation purposes)
Several classes of ligands bind to nAChR. These include
small molecules such as the endogenous agonists acetyl-
choline and carbamylcholine, small peptides including
the lophotoxins and α-conotoxins (CTx), and large pep-
tide toxins isolated from snake venoms (e.g., α-bungaro-
toxin, α-cobratoxins). α-Conotoxins that are specific for
muscle AChRs include MI, GI and SI, and contain three
residues in the first loop and five in the second. Muscle-
specific α-conotoxins can be further subdivided according
to their ability to select between the two AChR binding
sites: MI and GI show 10,000-fold differences between the
two binding sites, whereas CTx SI shows a 100-fold differ-
ence [6-8]. Because of their marked selectivity for the
peripheral and neuronal forms of the receptor, as well as
discrimination between nAChR binding sites, these toxins
are valuable for probing structure-function relationships
in various nAChR subtypes. The α-conotoxins are 12–18
residues long and are characterized by the presence of two
conserved disulfide bonds and two loops in the peptide
backbone between the cysteines. These small peptides are
known to distinguish between the two antagonist binding
sites of nAChRs [9], for example d-tubocurarine selec-
tively blocks the interactions of α-conotoxins GI and MI
with their higher affinity binding site on Torpedo recep-
tors, suggesting that they have a higher affinity for the ace-
tylcholine binding site near the α/γ subunit interface
[8,10]. This is also consistent with another important class
of nAChR antagonists, α-neurotoxins from snake venom,
which utilize a common binding core consisting of key
invariant residues to interact with subtype-specific recep-
tor residues. The evidence for this comes from various
mutational analyses, photoaffinity labeling data, NMR
and X-ray studies [11,12]. α-Neurotoxins from Elapid and
Hydrophiid snake venoms belong to the three-finger toxin
superfamily of polypeptides containing 60–74 amino
acid residues. The characteristic feature of all three-finger
toxins is their distinctive structure, formed by three adja-
cent loops that emerge from a small, globular, hydropho-
bic core that is cross-linked by four conserved disulfide
bridges [12].
It has long been known that the muscle-type nAChR
undergoes conformational transitions between "basal"
(resting), desensitized (closed) and open (active) channel
states, each with distinctive affinities for acetylcholine
[13]; and it has been proposed that α-neurotoxins stabi-
lize the resting state of nAChR [14]. However, despite
extensive studies on the gating mechanism of nAChR
when it binds small agonists such as ACh, and molecular
dynamics studies on the structural motions of homomeric
α7 nAChR [15-17], there have been few in-silico studies of
the dynamics and interaction of larger antagonists with
nAChR. Because of the size of these receptors (~290 kDa),
the only direct structure determinations have been at
medium resolution (~4 Å) using electron microscopy [3].
Nicotinic acetylcholine receptors have been implicated in
the pathophysiology of several neuropsychiatric disor-
ders, including schizophrenia, Alzheimer's disease, Par-
kinson's disease, and Tourette's syndrome [18]; the
development of clinically and experimentally useful drugs
depends in part on determining the structural features of
a ligand that contribute to its affinity and specificity.
Therefore, more detailed structural analyses of nAChRs
and their complexes with agonists and antagonists would
be useful for designing more specific ligands and drugs.
In the current study, the binding mode of T.nAChR with
two antagonists, an α-conotoxin and a long-chain α-neu-
rotoxin, was determined. Also, the structural dynamics of
the LBD of T.nAChR were examined during a nanosec-
ond-scale molecular dynamics simulation without the lig-
and (apo form) and in the presence of each of the two
antagonists. The major goal was to observe and compare
the conformational changes in the LBD in the presence of
these antagonists over this time period, and to examine
the structural determinants that govern the binding of two
inherently potent antagonists of different sizes. The mod-
els are based on the extracellular domain of Torpedo mar-
morata (2BG9) nAChR, which appears to exist in the basal
or resting state (a suitable conformation for binding to α-
neurotoxins) in complex with a long-chain α-neurotoxin
from  Naja Naja oxiana cobra venom (PDB accession
number:1W6B) [20] and an α-conotoxin from C.
geographus (PDB accession number:1XGA).
Results and discussion
An overall view of the nAChR complexes with antagonists
nAChR in complex with long chain neurotoxin NTX-1
According to our model, NTX-1 in complex with T.nAChR
is located about 35  from the membrane surface (Fig. 1A–
B). The tip of the toxin central loop plugs deeply into the
receptor, at the interfaces formed between two subunits:
alpha1 with gamma, and alpha2 with delta (not shown
here). The toxin lies almost equatorially to the extracellu-
lar domain of the nAChR, as previously suggested for the
interaction of short- and long-chain α-neurotoxins with
nAChRs [4,21-25] with its concave side facing the α1 sub-
unit and loops I and III oriented towards the top and bot-
tom of the receptor respectively (see Fig. 1A). The toxin
molecular axis, defined by its central three antiparallel
beta sheets, lies at ~85° relative to the main and ~80° to
the median axis of the receptor. The tip of the toxin central
loop II is positioned slightly under the C-loop in a small
cavity located in the interface between the α1 and γ subu-
nits and makes several contacts with functional loops
from the principal (α1) and complementary (γ or δ) sub-
units. The only difference lies in the angle of the toxin axis
relative to the main (α) and complementary (γ) binding
sites, which is slightly different from the previously-
reported Cbtx-AChBP complex [26]. Absence of a mem-Theoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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brane lipid bilayer and the long dynamic C-tail of the
toxin would inevitably affect the binding mode. Table 1
shows the main participating residues from toxin NTX-1,
making contacts with the main (alpha) and complemen-
tary (gamma) binding sites from the initial complex
obtained after docking (other amino acid residues partic-
ipating in the interactions of NTX-1 with the receptor (α-
γ) after the 7 ns MD simulation are shown [see Supple-
mentary table 3 in additional file 1]. These anchor points
have been reported to be the main interacting areas in
long-chain α-neurotoxins [21,26-31]. Various experimen-
tal studies have shown that receptor fragment 184–200
from the α1 subunit (corresponding to the C-loop) is
important for long-chain α-neurotoxin binding
[11,23,26,29,32], where residues K185, W187, Y189,
Y190, T191, C192, P194, Y198 and W149 have been
reported to interact directly with α-bungarotoxin and α-
cobratoxin [11]. In addition, residues W55, L119 and
E176 from the complementary binding site (gamma sub-
unit) are reported to interact mainly with the central loop
of long-chain α-neurotoxins (loop II) [23]. These residues
have been shown to be highly conserved among all spe-
cies of nAChR to allow proper binding of agonists such as
Ach and competitive antagonists through cation-p and
hydrophobic interactions [11,33]. The functionally
important residues for the Torpedo receptor are all located
on the concave surface of short-chain and long-chain α-
neurotoxins with the most critical residue, Arg35 (Arg33
Binding mode of NTX-1 with ligand binding domain of Torpedo nAChR from front (A) and top (B) view Figure 1
Binding mode of NTX-1 with ligand binding domain of Torpedo nAChR from front (A) and top (B) view. (C) and 
(D): Binding mode of 1XGA with ligand binding domain of Torpedo nAChR from front and top view, respectively.Theoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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in α-cobratoxin), located at the tip of loop II [12]. As can
be seen in table 1 [and table 3 additional file 1], Arg 35
(corresponding to Arg33 and Arg36 in α-cbtx and α-bgtx,
respectively) located at the tip of loop II in the toxin is sur-
rounded by the aromatic residues Trp149, Thr150 (loop
B), Tyr190 (loop C) Tyr93 (loop A) from the alpha1 and
leu118, Pro 119 (loop E), Trp54, Glu56 (loop D),
Glu175, Asp 176 (loop F) from the gamma subunits,
which is in good agreement with previously reported
complexes. It has been proposed that α-neurotoxins com-
pete with acetylcholine by introducing the positive charge
of Arg35 into the ligand-binding pocket of the receptor
[12]. This residue makes its main hydrophobic contacts
with Trp149, Asn94, Tyr93 and Tyr190 from the alpha1
and leu118, Trp54 from the gamma subunit (see table 1).
In summary, our complex model is in good agreement
with earlier predictions [19], suggesting that long chain
alpha-neurotoxin NTX-1 interacts similarly in many ways
to other long-chain α-neurotoxins in binding to nAChR.
nAChR in complex with alpha-conotoxin 1XGA
Generally, α-conotoxin GI shows higher affinity for Tor-
pedo nAChRs in the α/γ site [7]. Our docking results con-
firm this, and filtering the docked complexes according to
the known interacting residues in the α/γ and α/δ inter-
faces (see Methods section) yielded apparently more "cor-
rect" results for the α/γ binding site (see Fig. 1D–E). The
complexes were checked in a viewer for proper position of
the ligand in the binding pocket, as well as the position of
the nitrogen atom in the aromatic cage; and eventually a
complex of 1XGA bound to the α/γ interface with opti-
mum interaction energy was chosen for further analysis.
Table 2 shows some of interacting residues involved in the
binding of α-conotoxin 1XGA to the alpha and gamma
subunits of T.nAChR. It has been shown that the binding
Table 1: Amino acid residues participating in interactions of NTX-1 with receptor interface determined by docking simulation.
T.nAChR subunit interface
NTX-1 Principal site (alpha 1) Complementary site (gamma) Average occupancy during MD
Loop I
Thr 6 Thr 191 Arg 186
Ile 8 Pro 194, Cys 193, Cys 192, Thr 191 Ile 172 Ile8 Thr 191 (α1) 0.8
Ile8 pro 194 (α1) 0.7
Ile8 Cys 192 (α1) 0.9
Loop II
TRp 31 Tyr 190, Val 188 Asp 176, Glu 175, Trp31 Val 188 (α1) 0.9
Trp31 Tyr 190 (α1) 0.9
Cys 32 Asp 176, Thr 37 Cys32 Asp 176 (γ) 0.9
Cys32 Glu 175 (γ) 0.9
Gly 33 Trp 54 Gly33 Asp 176 (γ) 0.9
Ser 34 Tyr 93 Leu 118, Trp 54, Ser34 Trp 54 (γ) 0.7
Ser34 Tyr 93 (α1) 0.6
Arg 35* Glu 175 Arg 35* Leu 118 (γ) 0.9
Arg 35* Trp 54 (γ) 0.9
Arg 35* Trp 149 (α) 0.9
Gly 36 Tyr 190 Gln 58
Lys 37 Lys 37 Glu (γ) 0.8
Val 38 Thr 191 Val38 Thr 191 (α1) 0.9
Ile 39 Thr 191, Cys 192 Ile Thr 191 (α1) 0.9
Loop III
Ser 52
Tyr 53 Tyr53 Leu 172 (γ) 0.9
C-Tail
Gln 70 Pro 194, Cys 193 Arg72 Cys 193 (α1) 1
Lys 71 Cys 193, Lys71 Cys 193 (α1) 1
Arg 72 Cys 193 Gln70 Cys 193 (α1) 1
Pro 73 Cys 192, Cys 193 Gln70 Pro 194 (α1) 0.9
Average occupancies of the main anchor point residues participating in interactions of NTX-1 with receptor (α/γ interface) after 7 ns molecular 
dynamics simulation and within 5 Å distance along the simulation trajectory.The critical residue Arg 35 at the tip of Loop II is marked with a star. 
Amino acids making hydrogen bonds are underlined.Theoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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sites for α-bungarotoxin and α-conotoxins only partially
overlap [34]. Comparison of the regions involved in the
interactions with α-neurotoxin NTX1 (table 1) and α-
conotoxin 1XGA (table 2) within T.nAChR confirms the
claim; it is obvious that certain regions such as residues
180–200, 91–94 in the alpha1 and some residues like
Leu118 and Trp54 in the γ subunit are important for bind-
ing to these antagonists. Mutational analysis has already
revealed that the positive charge of His10 is not essential
while that of Arg9 is essential; the side chains of Arg9 and
His10 project prominently away from the structure [7].
This protruded surface acts as the recognition site for the
α/γ binding site, and it has been proposed that the region
around position 9 in the α-conotoxins is oriented toward
the δ and γ subunits of the nicotinic receptor [7]. Fig. 2
shows the positions of side chains Arg9 and His10 in α-
conotoxin 1XGA relative to the alpha and gamma subu-
nits in T.nAChR; as can be seen in Fig. 2C, the protrusion
of the conotoxin molecule is located exactly in the inter-
face between the subunits. Table 2 summarizes the main
contacts between conotoxin 1XGA and subunits alpha1/
gamma. Comparing this to the α-neurotoxin NTX-1 con-
tacts at the very same interface, it is not unreasonable to
presume that the side chains of Arg 9 and Arg 35 in cono-
toxin and snake neurotoxin molecules, respectively,
mainly contact via hydrophobic and cation-π interactions
(see tables 1 and 2). Even though long chain α-neurotox-
ins make multiple contact points with the receptor (men-
tioned earlier) and it has been shown that their binding
site only partly overlaps with that of α-conotoxins, the rel-
ative similarity seen between their counterparts located in
the alpha and gamma subunits is notable: Trp149 and
region 90–94 in the alpha subunit and Leu118, Trp54 and
Asp176 in the gamma subunit are among the common
residues making contacts with the "main" parts of both
toxin molecules.
Motions in the LBD of nAChR
Structure stability and fluctuations
The root mean square deviation (RMSD) is an indicator of
the structural stability of a protein in a given environment.
The RMSD plot of the Cα atoms in nAChR in the apo (lig-
and-free) form and in complex with toxin molecules as a
function of time for all subunits, and the average structure
relative to the starting model, are shown in Fig. 3. The
RMSD increases rapidly at first owing to thermal vibra-
tions and improper interactions; the deviations seen are
not unexpected for a system of this size. Comparison of
the RMSD plots for the apo and complex forms shows no
marked differences between these two structures; how-
ever, the complex form of the LBD with α-neurotoxin
seems to be slightly stabilized. Discarding the first 1500 ps
of the MD trajectory (the time needed for the system to
become relatively stable), detailed analysis of the LBD
Table 2: Amino acid residues participating in interactions of conotoxin 1XGA with the α/γ receptor interface determined by docking 
simulation, as well as average occupancies of the main anchor point residues participating in interactions after 7 ns molecular 
dynamics simulation along the trajectory.
T.nAChR subunit interface
1-XGA Principal site (alpha 1) Complementary site (gamma) Average occupancy during MD
GLU 1
CYS 2
CYS 3
ASN 4 Thr 191, Cys 192 Asn4 Thr191 0.9
Asn4 Cys192 0.8
PRO 5
ALA 6 Tyr 190, Val 188 Ala 6 Tyr190 0.5
Ala 6 Val 188 0.4
CYS 7 Tyr 190 Cys 7 Tyr 190 0.8
GLY 8 Trp 54
ARG 9* Trp 149, Val 91, Leu 92, Asp 99, Tyr 198 Leu 118, Trp 54, Thr 37, Asn 38 Arg9* Trp 149 0.7
Arg9* Leu 92 0.9
Arg9* Trp 54 0.9
Arg9* Thr 37 0.8
Arg9* Asn 38 0.8
HIS 10 Leu 118, Tyr 116, Leu 108, Arg 78 His10 Leu108 0.8
His10 Arg 78 0.8
TYR 11 Trp 54, Thr 35, Asp 176 Tyr11 Trp54 0.9
Tyr 11Asp 176 0.7
SER 12 Glu 56, Leu 118, Lys 33 Ser 12 Leu118 0.4
CYS 13 Tyr 116 Cys13 Tyr116 0.5
The critical residue Arg 9 is marked with an asterix. Amino acids making hydrogen bonds are underlined.Theoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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Position of residues His10 and Arg9 in 1XGA relative to the alpha and gamma subunits (A) before and (B) after MD simulations Figure 2
Position of residues His10 and Arg9 in 1XGA relative to the alpha and gamma subunits (A) before and (B) 
after MD simulations. (C) Protruding surface of 1XGA between the two subunits, top view.Theoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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The RMSD of all subunits and the average in apo and in complex forms of the LBD Figure 3
The RMSD of all subunits and the average in apo and in complex forms of the LBD. The color represents each sub-
unit as in Figure 1: α1, β, δ, α2 and γ are colored yellow, blue, green, red and violet, respectively. The average of all subunits is 
shown in black.Theoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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motions will give important information about the struc-
ture-function relationship [see Supplementary figure 6 in
Additional file 2]. It seems that upon binding of the α-
neurotoxin NTX-1, the relative stability of the lower third
of all subunits in the LBD increases substantially, the only
exception being the second binding site (alpha2/delta)
where the C-loop and Cys loop show more intense fluctu-
ations. On the other hand, RMSD plots of the C-loop, F-
loop and Cys loop of the LBD of the receptor in complex
with α-conotoxin 1XGA shows local rigidity only within
some subunits and it seems that binding of conotoxin
1XGA, because it is smaller, does not confer the same
effects at least during the very early stages of binding.
When the conotoxin binds, the stability of the C-loop
decreases in subunits alpha1, beta, and to a lesser extent
gamma. While RMSD of the C-loop in all subunits in
complex form indicates a more stabilized local arrange-
ment, the Cys-loop and F-loop show more deviations
compared to the apo form of LBD; this is specifically seen
in the case of the two alpha subunits. Here again, the
decrease in local fluctuations in the C-loops is somehow
concerted with an increase in movements in other impor-
tant loops such as the Cys- and F-loops [see Supplemen-
tary figure 7 in additional file 3].
A Root-mean square fluctuation (RMSF) provides more
detailed information on the mobilities of residues relative
to the average structure. The RMSF of the Cα atoms, and
details of the RMSF of subunit α in apo form and as a
complex of the LBD with toxin molecules, are shown in
Fig. 4. Excluding the chain terminus, the mobile parts of
the apo structure lie in the helix 3–13 and loops 23–26
(β1–β2 loop), 62-74 (β2–β3 loop), C-loop, Loop A, Cys
loops and F-loop (Fig. 4). For the NTX1-LBD complex
form, these fluctuations become more intense in the C-
loops in subunits alpha2, delta and gamma, and the F-
loop in alpha2; but they are restricted in the C-loop of α1,
F-loop in gamma, Cys loop and loop A in alpha2, and Cys
and F-loop in delta (Fig. 4A). It seems that the increase in
fluctuations in C-loop regions is concerted with decreased
fluctuations in the Cys loop among subunits. There is an
explanation for the decreased fluctuations in the C-loop
in subunit alpha1 and the F-loop in gamma: these are the
regions directly involved in interaction with a bulky toxin
molecule, therefore the motions of residues there are
more restricted.
An interesting feature of the 1XGA-LBD complex is the
local increase in the RMSF of subunit alpha1 relative to the
apo form and other subunits (see Fig. 4B). This behavior
was not observed in any of the other simulations; the rea-
son for it seems to be a local perturbation caused by the
presence of the ligand in the binding pocket in the early
stages. Conotoxin 1XGA is smaller than α-neurotoxin
NTX-1, with obviously fewer multi-point contacts and a
much less flexible structure, which probably could not
hinder fluctuations in this region.
Binding site changes and subunit interfaces
Movement of the C-loop
Given the different natures of the component subunits in
heteromeric nAChRs, it would be expected that different
structural changes take place in binding sites and at the
subunit interfaces. It is suggested that the two alpha subu-
nits have an "open" arrangement in the resting state of
T.nAChR (2BG9) [3], making the ligand-binding pocket
accessible to the agonist/competitive antagonist binding.
An important motion in the simulation takes place in the
C-loop region that forms one side of the binding site
(main side). In order to measure the movement of the C-
loop in the binding pocket, the distances between the Cαs
of residues Cys 192 at the tip of the C-loop in alpha sub-
units, and Pro119 in complementary subunit gamma/
Pro121 in delta (and similar positions in other non-alpha
subunits), were measured during the 7 nanosecond simu-
lations [see Supplementary figure 8 in additional file 4].
An interesting observation in the binding site is the "flap-
ping" of the C-loop in the two alpha subunits in the apo
form; this distance is usually greater for subunits alpha1
and alpha2  in 2BG9. The C-loop in alpha subunits
remains "opened" during the 7 ns simulation, hovering
around 20 Å; while in beta, gamma and delta the "lid"
tends to close the binding pocket. Similar results have also
been observed by others [15,17], confirming that the C-
loop is mobile in apo conformations and does actually
swing out. C-loop movement is apparently limited in
alpha1 owing to the presence of the bulky toxin molecules
in the binding site; the interactions with binding site and
C-loop (discussed earlier) therefore restrict movements in
this region (Fig. 4). In the alpha2 subunit in the LBD-
NTX1 complex, the distance increases constantly and the
C-loop continues to move outward. It can be seen that
when the toxin binds in one of the two binding sites
known for the competitive antagonist, the overall move-
ment of the C-loop during the 7 ns MD simulation in
alpha2 and beta is towards a more "open" position, mak-
ing the second binding site more accessible to ligand
binding; while in alpha1, delta and gamma it tends to
move inward and form a more closely packed pocket. The
situation is almost the same for the 1XGA-LBD complex;
the only difference seen here is that the C-loop movement
in the alpha2 subunit behaves like alpha1 and is clearly
limited compared to the apo form. In the case of subunits
delta and gamma, again the lid tends to close during the
simulation.
Local rearrangement associated with α-neurotoxin binding
As mentioned earlier, there are networks of loops at the
interface between the LBD and TMD that couple ligand
binding to channel gating. Domains C (C-loop) and F (F-Theoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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Root mean square fluctuation (RMSF) of the apo form of LBD (black) and the complex (gray) relative to their average structure  in the NTX1-LBD complex (A) Figure 4
Root mean square fluctuation (RMSF) of the apo form of LBD (black) and the complex (gray) relative to their 
average structure in the NTX1-LBD complex (A). RMSF of α and γ subunits in apo (black) and complex forms (gray) for 
1XGA-LBD complex (B).Theoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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loop) are two main constituents of the binding site, and
of these, the C-loop exhibits more obvious displacement
upon binding of agonists or competitive antagonists. The
Cys-loop is another pivotal point in coupling binding to
gating, since it is located at the interface between the LBD
and the M2–M3 loop in TMD. Therefore, a closer look at
the interactions within these locations could lead us to the
initial mechanisms that transfer local changes in the bind-
ing site to the pore domain.
Interactions among the K145, D200 and Y190 triad
One such interaction is through salt bridges formed
between Arg 206 and Glu 45, located at the bottom of the
LBD, which is then transferred to the transmembrane hel-
ices M2–M3 [3,35]. It has not been possible to study this
currently owing to the absence of the transmembrane
domain. The other important intra-subunit interaction is
between three conserved residues at the main ACh bind-
ing site (α subunit): Lys 145, Asp 200 and Tyr 190. Kinetic
analysis and site-directed mutagenesis, as well as struc-
tural modeling of AChBP with ligand-bound (carbamyl-
choline) and ligand-free conformations, have recently
shown that local rearrangements associated with agonist
binding propagate through beta strands to the pore
domain [35-37]. By analogy with the AChBP in the resting
state of the muscle type nAChR, K145 and D200 in the C-
loop are proposed to pair through electrostatic forces, and
Y190 is out of register. When the agonist binds, Y190 is
drawn towards the K145/D200 pair and pulls K145 away
from D200 [36]. These local displacements could propa-
gate to the channel via β-strands 7 (harboring K145) and
10 (harboring D200), which are linked to the M2–M3 and
M1 transmembrane domain respectively. Among these
three residues, Y190 is directly linked to the ACh binding
site. It is located in the aromatic cage surrounding the pos-
itively-charged agonist; in the case of α-neurotoxins as
competitive antagonists, Arg36 (Arg35 in NTX-1) and
Arg9 in α-conotoxin 1XGA play the role of positively-
charged agonist. In our complex model, Tyr190, located at
the C-loop, actually moves about 3.5 Å towards Lys145; it
was shown previously that in the complex form, the C-
loop is drawn slightly towards the binding pocket after 7
ns MD simulation. Nevertheless, this movement has little
or no effect on the interaction between Lys145 and
Asp200 during the simulation. When the toxin binds, it is
clearly seen that Lys145 and Asp200 have faced towards
each other after 7 ns MD simulation, making the distance
between these residues even less relative to the apo form
(see Fig. 5). This decrease in distance stabilizes the electro-
static force between the residues, so the salt bridge
between K145/D200 pairs not only remains intact but
also strengthens; while in the apo form of the receptor this
distance is variable, making the salt bridge more labile
than in the complex form (see Fig. 5). A possible explana-
tion for this is that in the ligand-free (apo) form, the
intense fluctuations of the C-loop make Tyr190 – located
at the tip of the C-loop – fluctuate in its place, often mov-
ing towards the K145/D200 pair. This fluctuation would
form transient electrostatic interactions between Y190
and the K145, which could have an effect on the salt
bridge between K145/D200 and weaken the electrostatic
bond. On the other hand, when the toxin binds, Tyr190 is
extensively involved in a hydrophobic interaction with
Trp31 after about two nanoseconds (not shown) and also
a transient hydrogen bond with Arg35 [see Supplemen-
tary table 3 in additional file 1]. These interactions would
largely restrict the Tyr190 fluctuations, leaving the K145/
D200 pair alone. In addition, because the toxin molecule
is bulky (compared to small agonists such as ACh or CCh)
the C-loop (or the "lid") is not closed completely and in
fact remains opened, therefore Tyr190 is never close
enough to K145 to disrupt its salt bridge with D200 effec-
tively. Since C-loop displacement would propagate to the
pore via β-strands 7 and 10 [see fig. 9 in additional file 5]
as an initial link to the gating cascade, it can be proposed
that restricting the motions in C-loops when an α-neuro-
toxin binds would prevent the large displacements of the
C-loop that ultimately results in channel opening. This is
in agreement with the assumption that binding of α-neu-
rotoxin stabilizes the "resting" or basal state of the recep-
tor, while the whole LBD without toxin bound to it seems
to move towards a more relaxed state or at least an inter-
mediate conformation between the open and resting
states.
In the conotoxin-LBD complex, Tyr190 is extensively
involved in hydrogen bonding with Tyr198 (alpha1) and
a non-bonded interaction with Cys7 (1XGA) during the
simulation (see table 2). The C-loop in the conotoxin-
LBD complex does not swing during the simulation [see
Supplementary figure 7 in additional file 3], so the residue
Tyr190 at the tip of the C-loop keeps its contacts during
the simulation with the ligand and also with Tyr198;
Tyr190 would therefore not disrupt the salt bridge
between the K145/D200 pair. Fig. 5 shows that the con-
tact between the K145/Asp200 pair is likely to be more
stable than in the apo form; also, because Tyr190 is par-
tially "fixed", the other contacts that depend on Tyr190
are much more stabilized. It seems that upon binding of
relatively large antagonists, the C-loop, which plays the
major role in transferring the local changes to the trans-
membrane domain, is extensively engaged in multiple
contacts with these ligands, which as a consequence sub-
stantially hinder its displacements.
Conclusion
Advances in drug discovery/drug design focusing on new
selective nAChR compounds are due to comprehensive
studies of their structures. Agonist or antagonist drugs that
selectively target receptor subtypes could be designed toTheoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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Distance between triads Lys 145, Asp 200 and Tyr 190 in apo and complex forms Figure 5
Distance between triads Lys 145, Asp 200 and Tyr 190 in apo and complex forms. The colors indicate each pair 
interaction: blue for Lys 145-Asp 200, magenta for Lys 145-Tyr 190 and yellow for Asp 200-Tyr190.Theoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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maximize the desired effect and minimize side-effects.
Toxins bind with higher affinity than endogenous ligands;
therefore an accurate prediction of their binding mode
can inform the design of more efficient lead compounds.
Details of interactions with subtype-selective antagonists
such as α-conotoxins and α-neurotoxins may prove bene-
ficial in the treatment of certain neuropathologies and dis-
eases.
In the current study, the interaction and dynamics of a
long-chain  α-neurotoxin and an α-conotoxin with
T.nAChR have been studied over a 7 nanosecond molecu-
lar dynamics simulation. The proposed model has shown
to accord with numerous experimental data, proving the
validity of the model and the methodology. Our docking
results confirm the claim that T.nAChR (2BG9) is in a
"basal" or "resting" state that favors binding to α-neuro-
toxins; this has been reported for α-cobratoxin in another
study [20]. Our results also confirm that the asymmetric
"resting" state of the LBD in nAChR has a dynamic nature.
Each subunit behaves specifically and individually, which
is a result of the hetero-pentameric conformation of the
receptor.
The formation of an aromatic cage upon agonist (ACh)
binding is believed to be one of the steps in the allosteric
pathway and α-neurotoxins are proposed to occupy and
even partially overlap the ACh binding site, so they are
deemed competitive antagonists. Our model supports the
fact that Arg35 at the tip of loop II in the NTX-1 mimics
the behavior of ACh: it is surrounded by W149, Y93 and
Y190 from the main side (α1subunit) and W54, L118
from the complementary side (γ subunit). Similar interac-
tions are seen for Arg9 in conotoxin 1XGA: this is also sur-
rounded by the aromatic residues W149, L92, Y198 from
the α subunit and W54, L118 from γ. The Arg9 residue in
α-conotoxin GI plays a key role in the interaction with the
high affinity binding site in T.nAChR [38], hence indicat-
ing that its counterparts in the α/γ interface would be use-
ful in designing more specific nAChR ligands.
Upon binding of the toxins, local rearrangements are
induced in the binding site. Some of these are similar to
what has previously been reported for small agonist bind-
ing; however, because of the bulk of the toxin molecules
and their multi-point contacts with the receptor, it seems
that these changes would not induce the same effects. The
salt bridge formed between K145 and D200 – which
should remain intact in the resting state – was labile and
would weaken gradually in the apo form owing to the
movements of the C-loop. However, in the complex form
of NTX1-LBD, this interaction remains intact, at least dur-
ing the first 7 nanosecond simulation, which would stabi-
lize the resting state as had been previously suggested for
α-neurotoxins. In the case of 1XGA-LBD this interaction is
again slightly more stabilized than in the apo form. The
importance of this triad is that its components are found
in α1 subunits in all species of muscle type and most neu-
ronal type nAChRs, suggesting a role in binding-to-gating
transduction. It should be mentioned that this displace-
ment is not the only allosteric link between binding and
gating [36], but it can give a clue on how the cascade of
interactions is triggered at the very early stages of binding.
Methods
Homology modeling
Models of the extracellular domain of T.marmorata
nAChR subunits were constructed using the program
MODELLER 9v1 [39]. Missing F-loop residues were
replaced and the F-loops were modeled again using the
"model-loop" command. Each subunit was constructed
separately. Beta, delta and gamma subunits were con-
structed using the B, C and E chains of T.marmorata
nAChR with substitution of 9, 10 and 7 residues respec-
tively. The subunits were then assembled into pentamers
using the same rotational angles in 2BG9. The modeled
structure was energy minimized using GROMOS96
implementations included in the Swiss-pdb Viewer (ver-
sion 3.7) [40].
Docking simulation
Docking was performed using the 3D-Dock suite [41,42].
The α-neurotoxin NTX-1 structures were chosen as snap-
shots from a 17 nanosecond MD trajectory (with 500 ps
intervals) along with 20 NMR structures [20] as input to
the program. The parameters set for the FTDock runs were
as follows: global surface thickness 1.4 , grid cell span
0.875  and search angle step 12°. A total of 9240 rotations
were evaluated, leading to 10,000 complexes for each
FTDock run. The complexes were then ranked using a pair
potential matrix that scores each complex according to an
empirically-derived likelihood of residue contacts in a
sample set of non-homologous interfaces in PDB. The
resulting complexes were filtered by applying three dis-
tance constraints known to exist in the binding interfaces
of ligands with subunits alpha/gamma and alpha/delta:
for long-chain α-neurotoxins the known interacting resi-
dues were Arg35 in the ligand and Trp55 in the gamma
subunit; Arg35 in the ligand and leu119 in the gamma
subunit; Asp29 in the ligand and Tyr 190 in the alpha sub-
unit. In the case of α-conotoxin the residues known to be
involved in the interaction of conotoxin GI and MI with
T.nAChR were selected for the filtration process [43,34];
for α-conotoxin 1XGA, all 35 NMR structures in the PDB
were used for the docking procedure. The known interact-
ing residues were Ala6, Cys7 and Arg9 and region 180–
200 in the alpha subunit. The distance cut-off for intermo-
lecular interface and non-bonded interactions was 10
(default). All other parameters for mean-field optimiza-
tion and rigid-body energy minimization in programTheoretical Biology and Medical Modelling 2009, 6:3 http://www.tbiomed.com/content/6/1/3
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Multidock (3D dock suite) were set as default. Subsequent
visual analysis in the Swiss-pdb Viewer allowed us to
reject those solutions that were not in at least rough
accordance with the available biochemical and mutagen-
esis data for long-chain alpha neurotoxins, and in the case
of α-conotoxin GI, the complex was compared to the X-
ray structure of the AChBP with conotoxin IMI (PDB
code:2C9T). The position of the toxin relative to each
interacting subunit and its distance from the base of the
LBD, as well as the positions of loops I and III relative to
the top and bottom of the LBD, were checked for agree-
ment with available experimental data for long-chain α-
neurotoxins in complex with nAChR and AChBP. Proper
complexes were found in both the α/δ and α/γ interfaces,
from which the solution in the alpha-gamma interface
(high affinity binding site for these antagonists) was
selected and subjected to the molecular dynamics simula-
tion.
Molecular dynamics (MD)
Further energy minimization and molecular dynamics
were carried out using Gromacs 3.3.1 [44-46] for the com-
plex and ligand-binding domain (LBD) of 2BG9 free of
ligand. The GROMOS96 [47] force field parameters were
employed for the simulations. Periodic boundary condi-
tions and the particle mesh ewald were used with non-
bonded cut-off of 10 , non-bonded pair list distance 10 ;
and the constraint algorithm used was LINCS [48]. In
each case, the system was first minimized in 500 steps
using the steepest descent algorithm. The box was neutral-
ized with the proper number of ions added and a 20 pico-
second position-restrained dynamics simulation followed
this, with Berendsen's temperature and pressure coupling
method [49]. Each simulation was continued for a further
seven (complex) and ten (LBD in apo form) nanoseconds.
The data were analyzed further using the analysis com-
mands in GROMACS, Program Ligplot [50], Spdb Viewer,
and VMD [51]. Analysis of the data over the simulations
was done at 10-ps intervals.
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